Aeglea BioTherapeutics, Inc.: Istoricul versiunilor

29 septembrie 2024

• actualăprec 03:0929 septembrie 2024 03:09‎ 127.0.0.1 discuție‎ 1.406 octeți +4‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 15:3618 septembrie 2024 15:36‎ Admin discuție contribuții‎ 1.402 octeți +1.402‎ Pagină nouă: Pagina dedicata companiei Aeglea BioTherapeutics, Inc. listata cu simbolul US.AGLE ==Descriere companie== Aeglea BioTherapeutics, Inc. (www.aeglea.com) is a clinical-stage biotechnology company. The Company is focused on developing human enzyme therapeutics to benefit people with rare metabolic diseases. The Company’s product candidates include pegzilarginase and AGLE-177. The Company's lead product candidate, pegzilarginase, is a recombinant human arginase one that enzyma...